Skip to main content

Table 2 Factors associated with insulin therapeutic inertia

From: Is therapeutic inertia present in hyperglycaemia, hypertension and hypercholesterolaemia management among adults with type 2 diabetes in three health clinics in Malaysia? a retrospective cohort study

Parameter

Crude Odd Ratio

(95% CI)

P value

Adjusted Odd Ratio

(95% CI)

P value

Insulin therapeutic inertia,n = 284

HbA1c < 7.0%a

 HbA1c ≥ 7.0%

0.09 (0.05, 0.17)

 < 0.001

0.10 (0.04, 0.24)

 < 0.001

 Age in year

1.02 (1.00, 1.04)

0.039

1.03 (0.99, 1.06)

0.078

Life event in the past 6 months (Noa)

 Yes

1.59 (0.84, 3.01)

0.159

2.01 (0.94, 4.28)

0.072

Diabetes complications (Noa)

 Diabetes complications (Yes)

0.64 (0.38, 1.07)

0.086

0.75 (0.33, 1.72)

0.499

Hypertension status (Noa)

 Yes

1.42 (0.94, 2.15)

0.092

1.20 (0.61, 2.35)

0.595

Diabetes Duration in year

0.93 (0.90, 0.96)

 < 0.001

0.92 (0.87, 0.98)

0.005

  1. HbA1c Glycated haemoglobin, CI Confidence interval
  2. aReferent groupNagelkerke R Square for this model is 0.29